To The Moon

Rocket Lab's Electron just hit a number no commercially developed rocket has reached faster: 100 launches. The milestone flight lifted off from Launch Complex 1 in New Zealand on November 14 and deployed the YAMATSUMI-II radar-imaging satellite for Japan's iQPS into a 575 km orbit (Rocket Lab press release). Wall Street shrugged: $Rocket Lab USA, Inc.(RKLB)$ fell 4% on Friday to $61.53, giving back part of a 15.9% weekly gain, even though the quarter behind the milestone was the best in company history (StockNewsroom). The question: has the market stopped paying for launch trophies? Short version — Electron proved the cadence; the stock now trades on Neutron, a rocket that has not flown once, and its new $70 million price tag.

Figure 1 — KPI card: the four numbers that define the setup. Sources: Rocket Lab press release, 14 Nov 2026; Q3 2026 8-K Ex 99.1, 9 Nov 2026.

One rocket, ten years, one repeat customer

Electron's first flight in May 2017 did not reach orbit; its hundredth, "The Mountain God Rises", succeeded nine and a half years later — the fastest run to 100 by any commercially developed rocket, the company said. This was the 11th launch for iQPS, all 11 successful since 2023, and iQPS has seven more dedicated launches booked through 2030 (press release). "Few rockets reach 100 launches in their total operational lifetime," founder and CEO Sir Peter Beck said, adding that "the next 100 Electrons are already booked." The scrappy small-launcher bet is now a repeatable cadence machine — and cadence is what Rocket Lab now tries to bottle again with Neutron.

The best quarter yet — and the market sold it anyway

Third-quarter revenue was $267.8 million, up 72.7% from $155.1 million a year earlier and above the $250-265 million guided range — the sixth consecutive record quarter (Rocket Lab 8-K Ex 99.1 via The Desk Research). Margins beat too: 33.6% GAAP against a guided 29-31%, 38.4% non-GAAP against 35-37%.

Figure 2 — Quarterly revenue; Q4 at guidance midpoint. Sources: Rocket Lab 8-K Ex 99.1 via The Desk Research; Growin.

The mix is the under-told story: product revenue of $197.5 million nearly doubled from $104 million a year ago, while services grew to $70.3 million from $51 million — growth is coming from spacecraft and components, not just launch.

Figure 3 — Product versus service revenue, Q3 year on year. Source: Rocket Lab Q3 2026 results via The Desk Research.

Peers got the same treatment. Intuitive Machines posted record revenue of $269.3 million, up 413.7% on Lanteris product revenue — and fell 7% the next day, with Clear Street citing dilution (AOL). AST SpaceMobile missed with $42.3 million against a $46 million consensus and sank as much as 9% (Yahoo Finance; AOL); Firefly lost 4%. The trigger was macro: hot producer-price data and a Fed official calling inflation broad-based dragged the Nasdaq lower, and high-beta space names fell hardest.

Neutron is the part the stock actually trades on

On October 14, Rocket Lab disclosed that a tank-component manufacturing issue had pushed Neutron's first flight from late 2026 into 2027; the Q3 filing now says "no earlier than 2027" (Cosmic Herald). Customers did not wait: Rocket Lab signed more than $515 million of Neutron contracts across eight missions in the quarter, lifting the pre-debut order book to 16, and raised base pricing to $70 million on several. The first 16 include a Space Force AMTI mission, and the next open slots fall in the 2030s (Air & Space Forces Magazine). Launch backlog stands at a record 117 missions after roughly $1 billion of new launch contracts in the quarter (8-K via The Desk Research).

The Pentagon wants this rocket flying often: the Office of Strategic Capital committed a $150 million conditional loan for Neutron cadence — recovery vessels and engine production — its third space-industry loan in three weeks (Air & Space Forces Magazine). But a backlog is not revenue: all 16 pre-debut missions assume a rocket that has already slipped once will hold its new schedule.

A seventh record in the guide; a P&L to watch

Fourth-quarter guidance: revenue of $270-290 million, GAAP gross margin of 34-36%, non-GAAP of 39-41%, an adjusted EBITDA loss of $14-20 million and net interest income of $45 million (8-K via The Desk Research). The revenue floor alone tops Q3's actual, and the adjusted loss keeps narrowing toward breakeven.

Figure 4 — Adjusted EBITDA loss narrowing; Q4 at guidance midpoint. Sources: Rocket Lab 8-K Ex 99.1 via The Desk Research; Growin (3Q25 adjusted EBITDA).

The GAAP picture is the counterweight. Net loss was $79.7 million, or -$0.12 a share, versus -$0.03 a year ago and worse than the roughly -$0.07 consensus (Growin). Operating expenses of $169.3 million blew through the guided $143-149 million range, including $21.3 million of Iridium transaction costs. Offsets: operating cash flow turned positive at $7.2 million, and the quarter ended with $4.45 billion in cash after an equity offering fully funded the shareholder-approved Iridium acquisition (8-K via The Desk Research; Cosmic Herald).

Bull Case

1. Demand is booked years out: a $3.57 billion backlog, up 52% in one quarter, and a Q4 guide whose floor exceeds Q3's record actual.

2. Pricing power: $70 million base Neutron pricing set before first flight — if Neutron flies, the step-up lands in future revenue per launch.

3. Balance sheet: $4.45 billion in cash, Iridium fully funded and shareholder-approved.

4. The street leans bullish: 11 buy ratings, zero sells, median target $103 versus a $61.53 close (Quiver Quantitative).

5. Cadence is proven: 100 Electron flights, 11-for-11 for iQPS, the next hundred already booked (press release).

Bear Case

Figure 5 — GAAP net loss, Q3 year on year. Sources: Rocket Lab 8-K Ex 99.1 via The Desk Research; Growin.

1. Losses are widening on a GAAP basis: -$79.7 million against -$18.3 million a year ago, with operating expenses above guidance.

2. Neutron slipped once already; delays historically compound, and much of the 117-launch backlog is tied to a rocket that has not flown.

3. Valuation is rich: roughly $41.4 billion of market cap against a -$0.12 EPS quarter; Piper Sandler cut its target to $58 from $83, below spot, and Cantor trimmed to $111 from $122 (StockNewsroom).

4. The tape is hostile to high-beta space — ASTS -9%, LUNR -7%, FLY -4% on Friday; momentum cuts both ways (Yahoo Finance; AOL).

5. Iridium integration adds execution load in the same window Neutron must fly.

Strategic Slam

• $RKLB(Rocket Lab)$ — own the cadence story only while Neutron milestones land; a second slip breaks the $70 million pricing narrative.

• $Intuitive Machines(LUNR)$ — record quarter, but $30.01 million of the beat leaned on a warrant fair-value gain — quality of beat is the question.

• $AST SpaceMobile, Inc.(ASTS)$ — revenue miss plus a second slip of the roughly 45-BlueBird target to mid-2027; the signal that matters is a firm date for BlueBirds 14-16.

• $Firefly Aerospace Inc.(FLY)$ — Jefferies cut to $30 from $35, kept Buy; $1.3 billion-plus of engine contracts tied to AST's rocket program make it indirect AST exposure.

• $Iridium(IRDM)$ — a deal-spread proxy for Rocket Lab execution; approval is in, closing is the event.

Catalyst Calendar

Figure 6 — Dated catalysts from the 100th launch to Neutron's debut window. Sources: Rocket Lab press release; Air & Space Forces Magazine; Rocket Lab 8-K.

• Flown, Nov 14, 2026: 100th Electron launch, YAMATSUMI-II deployed for iQPS (press release).

• Q4 results, early 2027, date unconfirmed: $270-290 million revenue guide on the table (8-K).

• Neutron first flight: no earlier than 2027 (company filing via Cosmic Herald).

• Iridium close: approved and funded; expected 2027 (Cosmic Herald).

• Through 2030: seven more dedicated iQPS launches booked (press release).

Before the Verdict

Figure 7 — Scenario matrix: Neutron timing against the tape. Sources: Rocket Lab Q3 2026 disclosures; author scenario logic.

Verdict

The 100th launch confirms what Electron built: a repeatable, revenue-generating cadence no small-launch peer has matched. But the stock's next leg is not a trophy — it is Neutron's first flight and whether the $70 million pricing holds. At $61.53 against a $103 median street target, this is a hold-to-catalyst, not a chase: the tape punishes this group on macro days, the GAAP loss is widening, and the rocket the backlog leans on has yet to fly. If Neutron flies on schedule in 2027, pricing re-rates the stock; if it slips again, Friday's 4% dip will look like a warning.

Key Takeaways

1. Electron reached 100 launches on Nov 14 — fastest commercial rocket to the mark — with iQPS as an 11-for-11 repeat customer.

2. Q3 revenue hit a record $267.8 million, up 72.7% year on year, beating guidance on revenue and margin.

3. The GAAP net loss quadrupled to $79.7 million, the adjusted EBITDA loss narrowed, and Q4 guides to $270-290 million of revenue.

4. Neutron slipped to 2027 yet booked 16 pre-debut missions at a raised $70 million base price, backed by a $150 million Pentagon OSC loan.

5. The stock trades on Neutron execution — street target $103 versus $61.53 — making the 2027 debut the decisive catalyst.

Is the market right to shrug off a hundred-launch trophy, or early to shrug off a company that just built one?

Tickers: $RKLB(Rocket Lab)$ $LUNR(Intuitive Machines)$ $ASTS(AST SpaceMobile)$ $FLY(Firefly Aerospace)$ $IRDM(Iridium Communications)$

Sources: Rocket Lab press release (GlobeNewswire), 14 Nov 2026; Rocket Lab Q3 2026 results, Form 8-K Exhibit 99.1 and Form 10-Q, 9 Nov 2026, via The Desk Research; Air & Space Forces Magazine; Defense Daily, via Cosmic Herald; Yahoo Finance; AOL; StockNewsroom week-46 review; Quiver Quantitative analyst tracker; Growin earnings review.

Disclaimer: Information only, not investment advice. Figures are attributed to named sources and may be revised. No positions are held in the tickers mentioned.